{"id":154,"date":"2017-11-18T06:06:26","date_gmt":"2017-11-18T06:06:26","guid":{"rendered":"https:\/\/plaza.umin.ac.jp\/~ACP\/?page_id=154"},"modified":"2018-09-21T23:24:21","modified_gmt":"2018-09-21T23:24:21","slug":"7ff586ad25c74ef934b1","status":"publish","type":"page","link":"https:\/\/plaza.umin.ac.jp\/~ACP\/home\/a-homepage-section\/7ff586ad25c74ef934b1","title":{"rendered":"In the clinic \u696d\u52d9\u30d5\u30ed\u30fc"},"content":{"rendered":"

In the clinic \u696d\u52d9\u30d5\u30ed\u30fc<\/h1>\n

ITC project\uff08In the clinic\u30d7\u30ed\u30b8\u30a7\u30af\u30c8\uff09\u306e\u696d\u52d9\u30d5\u30ed\u30fc\u3092\u63b2\u8f09\u3044\u305f\u3057\u307e\u3059\u3002<\/p>\n

\u30a2\u30c3\u30d7\u30c7\u30fc\u30c8\u306b\u95a2\u3057\u3066\uff1a<\/strong><\/h2>\n

In the Clinic\u696d\u52d9\u30d5\u30ed\u30fc\u3092\u30a2\u30c3\u30d7\u30c7\u30fc\u30c8\u3059\u308b\u969b\u306b\u3001\u5404\u30c1\u30fc\u30e0\u4ee3\u8868\u8005\u306b\u306a\u308b\u3079\u304f\u9023\u7d61\u3059\u308b\u3088\u3046\u306b\u81f4\u3057\u307e\u3059\u3002<\/p>\n

 <\/p>\n

20180906\u3000ITC006_IBS_\u7528\u8a9e\u7d71\u4e00\u6848\u3092\u30a2\u30c3\u30d7\u30c7\u30fc\u30c8\u3057\u307e\u3057\u305f\u3002<\/span><\/p>\n

20180904\u3000ITC005_Migraine_\u7528\u8a9e\u7d71\u4e00\u6848\u3092\u30a2\u30c3\u30d7\u30c7\u30fc\u30c8\u3057\u307e\u3057\u305f\u3002<\/span><\/p>\n

20180814\u3000\u7ffb\u8a33\u30c1\u30fc\u30e0\u306e\u696d\u52d9\u3001PRC\u59d4\u54e1\u76e3\u4fee\u306e\u696d\u52d9\u306e\u90e8\u5206\u3067\u3001\u3054\u6ce8\u610f\u3044\u305f\u3060\u304d\u305f\u3044\u90e8\u5206\u3092\u30a2\u30c3\u30d7\u30c7\u30fc\u30c8\u3044\u305f\u3057\u307e\u3057\u305f\uff08\u30a2\u30c3\u30d7\u30c7\u30fc\u30c8\u90e8\u5206\u304a\u3088\u3073\u3001\u524d\u56de\u3082\u8a18\u8f09\u3055\u308c\u3066\u3044\u305f\u304c\u518d\u5ea6\u3054\u78ba\u8a8d\u3044\u305f\u3060\u304d\u305f\u3044\u70b9\u3092\u3001\u3053\u306e\u30aa\u30ec\u30f3\u30b8\u5b57\u3067\u8a18\u8f09\u3057\u3066\u3042\u308a\u307e\u3059\uff09\u3002<\/span><\/p>\n

 <\/p>\n

\u672c\u30d7\u30ed\u30b8\u30a7\u30af\u30c8\u5168\u4f53\u3092\u901a\u3057\u3066\uff1a<\/p>\n

\u65e5\u672c\u8a9e\u8a33\u306b\u306f\u3001ACP\u7c73\u56fd\u672c\u90e8\u304b\u3089\u306e\u6307\u793a\u3067\u3001\u4e0b\u8a18\u306e\u6587\u8a00\u304c\u5165\u308a\u307e\u3059\u3002\u5404\u62c5\u5f53\u8005\u304c\u8cac\u4efb\u3092\u6301\u3063\u305f\u7ffb\u8a33\u3092\u884c\u3046\u3088\u3046\u304a\u9858\u3044\u3044\u305f\u3057\u307e\u3059\u3002<\/strong><\/p>\n

\u65e5\u672c\u8a9e\u8a33\u306b\u3042\u305f\u3063\u3066\u306e\u6ce8\u610f\uff1a<\/span><\/p>\n

\u7ffb\u8a33\u306e\u6b63\u78ba\u6027\u306b\u3064\u3044\u3066\u306f\u3001ACP<\/span>\u65e5\u672c\u652f\u90e8\u304c\u8cac\u4efb\u3092\u8ca0\u3046\u3082\u306e\u3067\u3042\u3063\u3066\u3001ACP<\/span>\u7c73\u56fd\u672c\u90e8\u304c\u8cac\u4efb\u3092\u8ca0\u3046\u3082\u306e\u3067\u306f\u306a\u3044\u3002\uff08\u4ee5\u4e0b\u7565\uff09<\/span><\/p>\n

1. \u62c5\u5f53\u8005\u306e\u5f79\u5272<\/strong><\/h1>\n

Table1. \u62c5\u5f53\u8005\u3068\u305d\u306e\u5f79\u5272<\/strong>
\n\n\n\n\n\t\n\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t
Term<\/th>Role<\/th>Responsibility<\/th>Person in charge<\/th>\n<\/tr>\n<\/thead>\n
ITC \u62c5\u5f53\u8005<\/td>\u65e5\u672c\u652f\u90e8\u5074\u3067ITC\u30d7\u30ed\u30b8\u30a7\u30af\u30c8\u5168\u822c\u3092\u3068\u308a\u307e\u3068\u3081\u308b<\/td>\u30d7\u30ed\u30b8\u30a7\u30af\u30c8\u5168\u822c\u304c\u9069\u5207\u306b\u5b9f\u65bd\u3055\u308c\u308b\u3088\u3046\u3001\u53d6\u308a\u307e\u3068\u3081\u308b<\/td>\u5317\u91ce\u5915\u4f73<\/td>\n<\/tr>\n
\u7ffb\u8a33\u8005<\/td>\u7ffb\u8a33\u3059\u308b
\n\u7d71\u4e00\u7528\u8a9e\u306e\u63d0\u6848<\/td>		\u5272\u308a\u5f53\u3066\u3089\u308c\u305f\u30d1\u30fc\u30c8\u306e\u7ffb\u8a33
\n\u7d71\u4e00\u3059\u308b\u3079\u304d\u7528\u8a9e\u3092\u63d0\u6848\u3059\u308b<\/td>		Table 2.<\/td>\n<\/tr>\n
\u76e3\u4feePRC\u59d4\u54e1<\/td>\u76e3\u4fee\u3059\u308b<\/td>\u6b63\u526f\u59d4\u54e1\u9577\uff1a\u76e3\u4fee\u30d1\u30fc\u30c8\u3092PRC\u59d4\u54e1\u306b\u5272\u632f\u308b\/\/ PRC\u59d4\u54e1\uff1a\u76e3\u4fee\u3059\u308b<\/td>Table 3.<\/td>\n<\/tr>\n
\u5c02\u9580\u76e3\u4fee\u8005<\/td>\u56fd\u5185\u306e\u5c02\u9580\u5bb6\u3068\u3057\u3066\u76e3\u4fee\u3092\u884c\u3046<\/td>\u56fd\u5185\u306e\u5c02\u9580\u5bb6\u3068\u3057\u3066\u306e\u89b3\u70b9\u304b\u3089\u306e\u30b3\u30e1\u30f3\u30c8\u3092\u3044\u305f\u3060\u304f<\/td>Table 4.<\/td>\n<\/tr>\n
QC \u62c5\u5f53\u8005<\/td>\u30c7\u30fc\u30bf\u306e\u4fe1\u983c\u6027\u3092\u4fdd\u8a3c\u3059\u308b<\/td>\u7ffb\u8a33\u8005\u304b\u3089\u63d0\u6848\u3055\u308c\u305f\u7528\u8a9e\u96c6\u306b\u57fa\u3065\u3044\u3066\u3001\u5c02\u9580\u7528\u8a9e\u304c\u7d71\u4e00\u7684\u306b\u4f7f\u7528\u3055\u308c\u3066\u3044\u308b\u3053\u3068\u3092\u78ba\u8a8d\u3059\u308b
\n\u30ac\u30ea\u30d7\u30eb\u30fc\u30d5\u306e\u969b\u306b\u6570\u5024\u3001\u533b\u85ac\u54c1\u540d\u306e\u6b63\u78ba\u6027\u3092\u62c5\u4fdd\u3059\u308b<\/td>		Table 5.<\/td>\n<\/tr>\n
ACP\u65e5\u672c\u652f\u90e8\u4e8b\u52d9\u5c40<\/td>\u65e5\u672c\u652f\u90e8\u30db\u30fc\u30e0\u30da\u30fc\u30b8\u306e\u7ba1\u7406<\/td>\u65e5\u672c\u652f\u90e8\u30db\u30fc\u30e0\u30da\u30fc\u30b8\u306b\u3001\u6c42\u3081\u3089\u308c\u308b\u6587\u66f8\u7b49\u3092\u9069\u5207\u306b\u63b2\u8f09\u3059\u308b\u3002<\/td>\u6587\u91ce\u51b4\u9999<\/td>\n<\/tr>\n
ACP<\/td>ACP \u672c\u90e8\u5074\u3067ITC\u30d7\u30ed\u30b8\u30a7\u30af\u30c8\u5168\u822c\u3092\u53d6\u308a\u307e\u3068\u3081\u308b<\/td>\u30d7\u30ed\u30b8\u30a7\u30af\u30c8\u5168\u822c\u304c\u9069\u5207\u306b\u5b9f\u65bd\u3055\u308c\u308b\u3088\u3046\u3001\u53d6\u308a\u307e\u3068\u3081\u308b<\/td>Aileen McHugh
\nPublishing Division<\/td>\n<\/tr>\n
Compositor<\/td>\u7d44\u7248<\/td>Chapter\u304b\u3089\u9001\u4ed8\u3055\u308c\u305f\u65e5\u672c\u8a9e\u8a33\u3092\u7d44\u7248\u3059\u308b<\/td>TBD<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/p>\n
\n

Table 2. \u7ffb\u8a33\u8005<\/strong>
\n\n\n\n\n\t\n\n\t\n\t\n\t\n\t\n\t\n\t
Project ID<\/th>Issue<\/th>\u7ffb\u8a33\u8005<\/th>Due date 1
\n\u7ffb\u8a33\u8005\u671f\u9650<\/th>\n<\/tr>\n<\/thead>\n
ITC001<\/td>Hepatitis C Virus<\/td>\u8056\u30de\u30ea\u30a2\u30f3\u30ca\u533b\u79d1\u5927<\/td>10\/31\/2017<\/td>\n<\/tr>\n
ITC002<\/td>Venous Leg Ulcers<\/td>\u6c34\u6238\u5354\u540c\u75c5\u9662
\n\u718a\u672c\u5927\u5b66<\/td>		12\/31\/2017<\/td>\n<\/tr>\n
ITC003<\/td>Preoperative Evaluation<\/td>\u6771\u4eac\u5927\u5b66
\n\u6a2a\u6d5c\u5e02\u7acb\u5927\u5b66<\/td>		2\/28\/2018<\/td>\n<\/tr>\n
ITC004<\/td>Aortic Stenosis<\/td>\u8056\u8def\u52a0\u56fd\u969b\u75c5\u9662
\n\u611b\u5a9b\u5927\u5b66<\/td>		4\/30\/2018<\/td>\n<\/tr>\n
ITC005<\/td>Migraine<\/td>\u6771\u6d77\u5927\u5b66
\n\u540d\u53e4\u5c4b\u7b2c\u4e8c\u8d64\u5341\u5b57\u75c5\u9662<\/td>		6\/30\/2018<\/td>\n<\/tr>\n
ITC006<\/td>Irritable Bowel Syndrome<\/td>\u660e\u77f3\u533b\u7642\u30bb\u30f3\u30bf\u30fc
\n\u795e\u6238\u5927\u5b66<\/td>		8\/31\/2018<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/p>\n
\n

Table 3. \u76e3\u4feePRC\u59d4\u54e1<\/strong>
\n\n\n\n\n\t\n\n\t\n\t\n\t\n\t\n\t\n\t
ProjectID<\/th>Issue<\/th>\u76e3\u4fee\u90e8\u5206\u306e\u5272\u308a\u4ed8\u3051<\/th>\u76e3\u4fee\u62c5\u5f53\u30b0\u30eb\u30fc\u30d7<\/th>Due date 2
\nPRC\u59d4\u54e1\u671f\u9650<\/th>\n<\/tr>\n<\/thead>\n
ITC001<\/td>Hepatitis C Virus<\/td>\u5b89\u85e4\u7dcf\u4e00\u90ce<\/td>PRC\u6709\u5fd7<\/td>11\/21\/2017<\/td>\n<\/tr>\n
ITC002<\/td>Venous Leg Ulcers<\/td>\u539f\u771e\u7d14<\/td>B\u30b0\u30eb\u30fc\u30d7<\/td>1\/21\/2018<\/td>\n<\/tr>\n
ITC003<\/td>Preoperative Evaluation<\/td>\u5927\u5cf6\u5eb7\u96c4<\/td>A\u30b0\u30eb\u30fc\u30d7<\/td>3\/21\/2018<\/td>\n<\/tr>\n
ITC004<\/td>Aortic Stenosis<\/td>\u539f\u771e\u7d14<\/td>C\u30b0\u30eb\u30fc\u30d7<\/td>5\/21\/2018<\/td>\n<\/tr>\n
ITC005<\/td>Migraine<\/td>\u5927\u5cf6\u5eb7\u96c4<\/td>B\u30b0\u30eb\u30fc\u30d7<\/td>7\/21\/2018<\/td>\n<\/tr>\n
ITC006<\/td>Irritable Bowel Syndrome<\/td>\u539f\u771e\u7d14<\/td>A\u30b0\u30eb\u30fc\u30d7<\/td>9\/21\/2018<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/p>\n
\n

Table 4. \u5c02\u9580\u76e3\u4fee\u8005<\/strong>
\n\n\n\n\n\t\n\n\t\n\t\n\t\n\t\n\t\n\t
Project ID<\/th>Issue<\/th>\u5c02\u9580\u76e3\u4fee\u8005<\/th>Due date 3
\n\u5c02\u9580\u76e3\u4fee\u671f\u9650<\/th>\n<\/tr>\n<\/thead>\n
ITC001<\/td>Hepatitis C Virus<\/td>\u5927\u5d0e\u5f80\u592b<\/td>12\/20\/2017<\/td>\n<\/tr>\n
ITC002<\/td>Venous Leg Ulcers<\/td>\u5927\u8535\u66a2<\/td>2\/20\/2018<\/td>\n<\/tr>\n
ITC003<\/td>Preoperative Evaluation<\/td>\u5e73\u5ca1\u6804\u6cbb<\/td>4\/20\/2018<\/td>\n<\/tr>\n
ITC004<\/td>Aortic Stenosis<\/td>\u5ddd\u540d\u6b63\u654f<\/td>6\/20\/2018<\/td>\n<\/tr>\n
ITC005<\/td>Migraine<\/td>\u99ac\u5834\u6cf0\u5c1a<\/td>8\/20\/2018<\/td>\n<\/tr>\n
ITC006<\/td>Irritable Bowel Syndrome<\/td>\u5c71\u672c\u8cb4\u55e3<\/td>10\/20\/2018<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/p>\n
\n

Table 5. QC\u62c5\u5f53\u8005<\/strong>
\n\n\n\n\n\t\n\n\t\n\t\n\t\n\t\n\t\n\t
Project ID<\/th>Issue<\/th>QC\u62c5\u5f53\u8005<\/th>Due date 3
\n\u7528\u8a9e\u7d71\u4e00<\/th>		Due date 5
\nQC\u671f\u9650<\/th>\n<\/tr>\n<\/thead>\n
ITC001<\/td>Hepatitis C Virus<\/td>\u6176\u61c9\u7fa9\u587e\u5927\u5b66<\/td>December 20, 2017<\/td>January 26, 2018<\/td>\n<\/tr>\n
ITC002<\/td>Venous Leg Ulcers<\/td>\u6176\u61c9\u7fa9\u587e\u5927\u5b66<\/td>February 20, 2018<\/td>March 26, 2018<\/td>\n<\/tr>\n
ITC003<\/td>Preoperative Evaluation<\/td>\u6176\u61c9\u7fa9\u587e\u5927\u5b66<\/td>April 20, 2018<\/td>May 25, 2018<\/td>\n<\/tr>\n
ITC004<\/td>Aortic Stenosis<\/td>\u6176\u61c9\u7fa9\u587e\u5927\u5b66<\/td>June 20, 2018<\/td>July 26, 2018<\/td>\n<\/tr>\n
ITC005<\/td>Migraine<\/td>\u6176\u61c9\u7fa9\u587e\u5927\u5b66<\/td>August 20, 2018<\/td>September 26, 2018<\/td>\n<\/tr>\n
ITC006<\/td>Irritable Bowel Syndrome<\/td>\u6176\u61c9\u7fa9\u587e\u5927\u5b66<\/td>October 20, 2018<\/td>November 28, 2018<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/p>\n
\n

<\/span>2. \u7ffb\u8a33\u30fb\u76e3\u4fee\u306b\u5148\u7acb\u3063\u3066<\/strong><\/h2>\n
\u3010\u304a\u9858\u3044\u3011\u7ffb\u8a33\u30c1\u30fc\u30e0\u3001QC\u62c5\u5f53\u30c1\u30fc\u30e0\u306e\u30e1\u30f3\u30d0\u30fc\u306f\u5168\u54e1\u3001ACP\u4f1a\u54e1\u306b\u306a\u3063\u3066\u304f\u3060\u3055\u3044\u3002<\/p>\n

Member\uff08\u6b63\u4f1a\u54e1\uff09\u3001Physician Affiliate Member\uff08\u30a2\u30d5\u30a3\u30ea\u30a8\u30a4\u30c8\u4f1a\u54e1\uff09\u3001Resident & Fellow-in-training Member\uff08\u6e96\u4f1a\u54e1\uff09\u3001Student Member\uff08\u5b66\u751f\u4f1a\u54e1\uff09\u306e\u3044\u305a\u308c\u304b\u9069\u5207\u306a\u3082\u306e\u306b\u305d\u308c\u305e\u308c\u3054\u5165\u4f1a\u4e0b\u3055\u3044\u3002<\/p>\n\n\n\n\n\t\n\n\t\n\t\n\t\n\t
Membership<\/th>Qualification<\/th>\n<\/tr>\n<\/thead>\n
\u6b63\u4f1a\u54e1
\nMember<\/td>		\u7dcf\u5408\u5185\u79d1\u5c02\u9580\u533b
\nABIM\uff08\u7c73\u56fd\u5185\u79d1\u5b66\u4f1a\u5c02\u9580\u533b\uff09\u53d6\u5f97\u8005
\nABIM\uff08\u7c73\u56fd\u5185\u79d1\u5b66\u4f1a\u5c02\u9580\u533b\uff09\u53d7\u9a13\u8cc7\u683c\u8005<\/td>\n<\/tr>\n
\u30a2\u30d5\u30a3\u30ea\u30a8\u30a4\u30c8\u4f1a\u54e1
\nPhysician Affiliate Member<\/td>		\u6b63\u4f1a\u54e1\u306e\u8cc7\u683c\u8981\u4ef6\u3092\u6e80\u305f\u3055\u306a\u3044\u533b\u5e2b<\/td>\n<\/tr>\n
\u6e96\u4f1a\u54e1
\nResidents & Fellows-in-Training Member<\/td>		\u521d\u671f\u7814\u4fee\u533b
\n\u521d\u671f\u7814\u4fee\u4fee\u4e86\u5f8c\u3067\u5185\u79d1\u7814\u4fee\u4e2d\u306e\u533b\u5e2b<\/td>\n<\/tr>\n
\u5b66\u751f\u4f1a\u54e1
\nStudent Member<\/td>		\u533b\u5b66\u90e8\u5b66\u751f<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n\n

\u5404\u30c1\u30fc\u30e0\u306e\u30ea\u30fc\u30c0\u30fc\u306f\u3001\u672c\u30d7\u30ed\u30b8\u30a7\u30af\u30c8\u53c2\u52a0\u306b\u969b\u3057\u3066\u5165\u4f1a\u3055\u308c\u305f\u65b9\u306e\u60c5\u5831(\u6c0f\u540d\u3001ACP\u4f1a\u54e1\u756a\u53f7\uff09\u3092\u5168\u54e1\u5206\u307e\u3068\u3081\u3066
\n– PRC\u59d4\u54e1\u9577 \u5927\u5cf6\u5eb7\u96c4 (acp.japan.prc1@gmail.com)
\n– PRC\u526f\u59d4\u54e1\u9577 \u539f\u771e\u7d14 (masumihara@gmail.com)
\n– ITC\u62c5\u5f53\u8005 \u5317\u91ce\u5915\u4f73 (yuka2011sendai@gmail.com)
\n\u5b9b\u306b2017\u5e7412\u670824\u65e5\u307e\u3067\u306b<\/strong>\u3054\u9023\u7d61\u304f\u3060\u3055\u3044\u3002<\/p>\n

\u5165\u4f1a\u306e\u624b\u7d9a\u304d\u7b49\u306e\u8a73\u7d30\u306fhttp:\/\/www.acpjapan.org\/admission\/<\/a>\u3000\u3092\u3054\u53c2\u7167\u304f\u3060\u3055\u3044\u3002\u90f5\u9001\u624b\u7d9a\u304d\u304c\u3042\u308a\u3001\u65e9\u6025\u306b\u5165\u4f1a\u624b\u7d9a\u304d\u958b\u59cb\u3057\u3066\u304f\u3060\u3055\u3044\u3002<\/fieldset>\n

 <\/p>\n

ITC \u62c5\u5f53\u8005\uff1a<\/strong>\u00a0\u5404\u7ffb\u8a33\u5bfe\u8c61\u306e\u8a18\u4e8b\u306b\u3001ITC0011<\/sup><\/span>, ITC0022<\/sup><\/span>,ITC0033<\/sup><\/span>, ITC0044<\/sup><\/span>, ITC0055<\/sup><\/span>, ITC0066<\/sup><\/span>\u3068\u3044\u3046\u5177\u5408\u306e\u30ca\u30f3\u30d0\u30ea\u30f3\u30b0\u3092\u884c\u3063\u305f\u3002\u4ee5\u964d\u306e\u30b3\u30df\u30e5\u30cb\u30b1\u30fc\u30b7\u30e7\u30f3\u306b\u306f\u7ffb\u8a33\u5bfe\u8c61\u7269\u306e\u30ca\u30f3\u30d0\u30ea\u30f3\u30b0\u3092\u7528\u3044\u308b\u3002
\n\u5404\u5f79\u5272\u8005\u306e\u671f\u65e5Due date 1, 2, …, 7\u3092\u8a2d\u5b9a\u3057\u305f\u3002\u5404\u5f79\u5272\u8005\u306b\u3001\u3053\u306e\u671f\u9650\u3092\u81ea\u5206\u3067\u78ba\u8a8d\u3059\u308b\u3088\u3046\u306b\u4fc3\u3059\u3002<\/p>\n

Table 6. Due date at a glance<\/strong>
\n\n\n\n\n\t\n\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t
Project ID<\/th>ITC001<\/th>ITC002<\/th>ITC003<\/th>ITC004<\/th>ITC005<\/th>ITC006<\/th>\n<\/tr>\n<\/thead>\n
Issue<\/td>Hepatitis C Virus<\/td>Venous Leg Ulcers<\/td>Preoperative Evaluation<\/td>Aortic Stenosis<\/td>Migraine<\/td>Irritable Bowel Syndrome<\/td>\n<\/tr>\n
\u65e5\u672c\u652f\u90e8
\n\u539f\u7a3f\u53d7\u53d6<\/td>		October 31, 2017<\/td>October 31, 2017<\/td>October 31, 2017<\/td>October 31, 2017<\/td>October 31, 2017<\/td>October 31, 2017<\/td>\n<\/tr>\n
Due date 1
\n\u7ffb\u8a33\u8005\u671f\u9650<\/td>		October 31, 2017<\/td>December 31, 2017<\/td>February 28, 2018<\/td>April 30, 2018<\/td>June 30, 2018<\/td>August 31, 2018<\/td>\n<\/tr>\n
\u76e3\u4fee\u30d1\u30fc\u30c8\u5272\u4ed8<\/td>November 1, 2017<\/td>January 1, 2017<\/td>March 1, 2017<\/td>May 1, 2017<\/td>July 1, 2017<\/td>September 1, 2017<\/td>\n<\/tr>\n
Due date 2
\nPRC\u59d4\u54e1\u671f\u9650<\/td>		November 21, 2017<\/td>January 21, 2018<\/td>March 21, 2018<\/td>May 21, 2018<\/td>July 21, 2018<\/td>September 21, 2018<\/td>\n<\/tr>\n
Due date 3
\n\u5c02\u9580\u76e3\u4fee\u671f\u9650<\/td>		December 20, 2017<\/td>February 20, 2018<\/td>April 20, 2018<\/td>June 20, 2018<\/td>August 20, 2018<\/td>October 20, 2018<\/td>\n<\/tr>\n
Due date 4
\nACP\u3078\u5165\u7a3f<\/td>		January 2, 2018<\/td>March 1, 2018<\/td>May 1, 2018<\/td>July 1, 2018<\/td>September 1, 2018<\/td>November 1, 2018<\/td>\n<\/tr>\n
ACP sends Translation to Compositor<\/td>January 9, 2018<\/td>March 8, 2018<\/td>May 8, 2018<\/td>July 9, 2018<\/td>September 10, 2018<\/td>November 8, 2018<\/td>\n<\/tr>\n
ACP Emails Compositor Proofs to Chapter<\/td>January 19, 2018<\/td>March 19, 2018<\/td>May 18, 2018<\/td>July 19, 2018<\/td>September 19, 2018<\/td>November 19, 2018<\/td>\n<\/tr>\n
Due date 5
\nQC\u671f\u9650<\/td>		January 26, 2018<\/td>March 26, 2018<\/td>May 25, 2018<\/td>July 26, 2018<\/td>September 26, 2018<\/td>November 26, 2018<\/td>\n<\/tr>\n
Due date 6
\nChapter Emails Corrected Compositor Proofs to ACP<\/td>		February 2, 2018<\/td>April 2, 2018<\/td>June 1, 2018<\/td>August 2, 2018<\/td>October 3, 2018<\/td>December 5, 2018<\/td>\n<\/tr>\n
ACP Emails Revised Compositor Proofs to Chapter<\/td>February 12, 2018<\/td>April 11, 2018<\/td>June 12, 2018<\/td>August 13, 2018<\/td>October 15, 2018<\/td>December 14, 2018<\/td>\n<\/tr>\n
Due date 7
\nChapter Approves Revised Compositor Proofs<\/td>		February 23, 2018<\/td>April 25, 2018<\/td>June 25, 2018<\/td>August 27, 2018<\/td>October 29, 2018<\/td>January 10, 2019<\/td>\n<\/tr>\n
ACP Posts Translations on Annals.org<\/td>March 13, 2018<\/td>May 8, 2018<\/td>July 10, 2018<\/td>September 11, 2018<\/td>November 13, 2018<\/td>January 22, 2019<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/p>\n
\n

3. \u7ffb\u8a33\u30fb\u76e3\u4fee<\/strong><\/h2>\n

\u7ffb\u8a33\u30fb\u76e3\u4fee\u306e\u30b9\u30c6\u30fc\u30b8\u6bce\u306b\u304b\u304b\u308f\u308b\u4eba\u306e\u5f79\u5272\u304c\u7570\u306a\u308b\u305f\u3081\u3001Figure 1. \u696d\u52d9\u30d5\u30ed\u30fc\u306b\u793a\u3057\u305f\u901a\u308a4\u3064\u306e\u76f8(PhaseI ~ Phase IV) \u306b\u5206\u3051\u3066\u696d\u52d9\u3092\u8aac\u660e\u3059\u308b\u3002<\/p>\n

Figure 1. Workflow<\/strong>\"\"<\/a><\/p>\n

<\/span>Phase I:<\/strong><\/em><\/h3>\n

ITC\u62c5\u5f53\u8005\uff1a<\/strong>ITC\u62c5\u5f53\u8005\u306f\u7ffb\u8a33\u3059\u308b\u8a18\u4e8b\u3092\u3001\u7ffb\u8a33\u8005\u304a\u3088\u3073\u6b63\u526f\u59d4\u54e1\u9577\u3078\u9001\u4ed8\u3059\u308b
\n\u7ffb\u8a33\u8005\uff1a<\/strong>\u7ffb\u8a33\u8005\u306f\u62c5\u5f53\u30d1\u30fc\u30c8\u3092Due date1\u307e\u3067\u306b\u7ffb\u8a33\u3057\u3001\u7ffb\u8a33\u7d50\u679c\u3092ITC\u62c5\u5f53\u8005\u3078\u9001\u4ed8\u3059\u308b\u3002\u7ffb\u8a33\u30b0\u30eb\u30fc\u30d7\u306e\u30ea\u30fc\u30c0\u30fc\u306f\u3001\u5c02\u9580\u7528\u8a9e\u7b49\u304c\u540c\u3058\u8a18\u4e8b\u306e\u4e2d\u3067\u8907\u6570\u500b\u6240\u51fa\u3066\u304f\u308b\u969b\u306b\u3001\u540c\u3058\u65e5\u672c\u8a9e\u306e\u7528\u8a9e\u306b\u306a\u308b\u3088\u3046\u7d71\u4e00\u3059\u308b\u3002\u7ffb\u8a33\u30b0\u30eb\u30fc\u30d7\u306e\u30ea\u30fc\u30c0\u30fc\u306f\u3001\u7d71\u4e00\u3059\u308b\u3079\u304d\u7528\u8a9e\u7b49\u306b\u3064\u3044\u3066\u3001\u4e0b\u8a18\u300c\u5225\u7d19\uff08\u7ffb\u8a33\u6642\u5099\u8003\uff09\u300d\u3092\u4f5c\u6210\u3057\u3066\u3001Due date1\u307e\u3067\u306bITC\u62c5\u5f53\u8005\u3078\u9001\u4ed8\u3059\u308b\u3002\uff08\u7ffb\u8a33\u4e2d\u3082ITC\u62c5\u5f53\u8005\u3089\u3068\u7d71\u4e00\u3059\u308b\u3079\u304d\u7528\u8a9e\u306b\u3064\u3044\u3066\u8b70\u8ad6\u3057\u3066\u304a\u304f\uff09<\/p>\n